Abstract:Objective Primary nocturnal enuresis (PNE) is the most common voiding problem in children. There is a great demand for the treatment of PNE despite absence of underlying diseases because it is socially unacceptable by and can be very distressing to the patients and their parents. We evaluated the efficacy of biofeedback (BFB) therapy in childrens with PNE to DDAVP treatment in a randomized control trial (RCT). Methods PNE children who were diagnosed by nephrologists or urologists of children's hospital of Fudan University were divided randomly into two groups from July 2005 to January 2006. The biofeedback group received computer-assisted biofeedback program, sphincter contraction and relaxation can be transformed into visual signals. Both therapies were carried out for one month and then three month's follow-up were taken. Parameters of follow-up included enuresis diary,urine flow rate and AQP2 in urine.Results 50 PNE patients were recruited (26 boys and 24 girls), whose mean age was (8.4±0.9) years. There was equilibrious in age and gender in two groups divided randomly. At the end of treatment, the cure rate was 40% and total effective rate was 64% in DDAVP group while there were 48% and 92% respectively in biofeedback group. Total effective rate in the biofeedback group was significantly higher than that in the DDAVP group. Three months later, the cure rate was 20%, total effective rate was 52% and relapse rate was 20% in the DDAVP group while they were 40%, 84% and 8% respectively in the biofeedback group. The total effective rate in the biofeedback group was still significantly higher than that in the DDAVP group. The relapse rate and the cure rate in the biofeedback group were not different from those in the DDAVP. Uroflowmetry findings showed that in the biofeedback group the maximum flow rate before the treatment、at the end of the treatment and three months later was (15.8±1.7) mL·~s -1 , (22.5±2.2) mL·~s -1 and (18.1±2.0) mL·~s -1 respectively;and voided volume was (141.7±20.6) mL, (201.1±15.1) mL and (156.4±31.5) mL respectively. Both results increased after the biofeedback treatment (P<0.05), but there was no difference between pre-treatment and the second follow-up. Ratio of normal flow curve was 28%, 60% and 58.3% respectively, which increased at the second follow-up (P<0.05). Ratio of patients who had coordinative detrusor-sphincter contraction was 40%, 72% and 66.3% respectively, which increased after the treatment but decreased three months later. In DDAVP group the voided volume before the treatment、at the end of the treatment and three months later was (192.8±51.5) mL, (127.1±47.6) mL and (182.5±47.3) mL respectively;and voiding time was (17.0±3.3) s, (10.2±5.2) s and (14.5±5.1) s respectively. Both results decreased after the treatment (P<0.05), but there was no difference between pre-treatment and at the second follow-up. Ratio of normal flow curve was 52%, 50% and 54.5% and ratio of patients who had coordinative detrusor-sphincter contraction were 36%, 37.5% and 40.9% respectively. Both results were not different from that before the treatment. Two bands of AQP2 (29 000 and 43 000) were detected in the morning urine. Density of the two bands of patients were (0.3±0.1) and (4.4±1.2) while they were (16.4±6.1) and (31.5±6.9) respectively in the controls. Results in patients were significantly lower than that of the controls. Density of 29 000 bands of patients in the DDAVP group before the treatment, at the end of the treatment and three months later were (0.2±0.1),(15.8±2.3) and (4.4±1.2) while they were (4.9±1.4),(17.0±2.8) and (6.4±2.4) of 43 000 respectively. Data at the end of the treatment were significantly higher than those before but three months later the results of 43 000 decreased. The data of patients in the biofeedback group was (0.4±0.2), (1.2±0.8), (2.9±1.3) in 29 000 while (3.9±1.9), (4.9±2.4) and (5.1±1.6) in 43 000, which was not different from that before the treatment. Conclusions Biofeedback and DDAVP are both effective therapies for PNE in children. Biofeedback is helpful in correcting voiding dysfunction and DDAVP can increase AQP2 protein in the urine. With higher effective rate within four month, biofeedback is strongly recommended. However better treatment outcome needs a multidisciplinary team of nephrologists, urologists and therapists.

Thrombocytopenia associated with PF3 antiplatelet activity against the sulfa component of trimethoprim-sulfamethoxazole.

The Effect of Biofeedback Treatment for Children with Non‐neurogenic Voiding Dysfunction: A Systematic Review and Meta‐analysis

Urotherapy and biofeedback resistant dysfunctional voiding: How to deal with?

[Efficacy of biofeedback therapy in children with functional constipation].

The effect of biofeedback on nonneurological dysfunctional voiding in children: A meta-analysis and systematic review

CLINICAL RESEARCH OF TREATMENT WITH BIOFEEDBACK FOR FUNCTIONAL CONSTIPATION OF CHILDREN

Exploring the Link between Stuttering and Phonology: A Review and Implications for Treatment

A randomized control trial study of biofeedback and DDAVP in children with primary nocturnal enuresis

Evolution of views on the functional anatomy of the vesicoureteral segment and etiopathogenetic features of vesicoureteral reflux in children

Can VideoUrodynamics Shape Management in Refractory Pediatric Lower Urinary Tract Dysfunction?

Occupational Therapy Role in Addressing Urinary Incontinence for Children with Incomplete Spinal Cord Injury through Biofeedback, a Case Series

Do Various Treatment Modalities of Vesicoureteral Reflux Have Any Adverse Effects in Pediatric Patients? A Meta-Analysis

The Effectiveness of Scoring and Bipolar Diathermy on Ear Cartilage Behavior: Ex Vivo Study

[Vesico-sphincteric dysfunction in children. Apropos of 85 cases, neurologic contexts excluded]

Asymmetrical Primary Vesicoureteral Reflux: Which Is The Best Surgical Strategy?

Urodynamics in Posterior Urethral Valve: Pursuit of prognostication or optimisation

Surgical management of high-grade vesicoureteral reflux in an 18-month-old female with a solitary kidney: A case report from a resource-limited setting

Long-term beneficial effects of mirabegron in pediatric patients with therapy-refractory neurogenic lower urinary tract dysfunction

Constrained multiple deployment problem in wireless sensor networks with guaranteed lifetimes

Primary vesicoureteral reflux

Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children